As Florida voters prepare for the upcoming gubernatorial election, the stances of major candidates on Florida cannabis policy have been detailed. A report by Ganjapreneur, citing the Florida Phoenix, indicates that all but one major candidate for governor opposes adult-use cannabis reforms, setting a clear direction for potential future regulation in the state.
This political landscape emerges after a 2024 adult-use legalization question, while securing a majority of votes, failed to meet the 60% voter threshold required for a constitutional amendment in Florida. Subsequent efforts for a 2026 ballot initiative also faced setbacks, with state officials invalidating thousands of submitted signatures under new policies, a decision upheld by the state Supreme Court.
Gubernatorial Candidates Detail Positions on Cannabis Policy
The candidates’ positions reflect a cautious approach to expanding cannabis access beyond the existing medical framework. The debate around Florida cannabis policy continues to be a point of discussion for voters and industry stakeholders.
- David Jolly (Democrat): The former Republican Florida Representative, now running as a Democrat, supports legalizing adult-use marijuana. His support is based on the premise that a majority of Floridians supported the legalization question in 2024.
- Byron Donalds (Republican): A current Florida Representative, Donalds stated during a campaign event that he does not support adult-use reforms. However, he expressed satisfaction with the current regulatory system for medicinal use. The report noted Donalds had previously admitted to low-level cannabis possession and selling small quantities as a youth.
- James Fishback (Republican): This Republican candidate opposes adult-use reforms but supports patient access for those with a legitimate medical purpose, specifically mentioning U.S. military veterans.
- Jay Collins (Republican): The current Lieutenant Governor stated on social media that he is “completely against legalizing marijuana,” citing concerns about the industry’s impact in other states.
- Paul Renner (Republican): The former House Speaker expressed opposition to “full blown recreational marijuana” last week, indicating he would campaign against it if it appeared on the ballot again, similar to Governor Ron DeSantis’s previous stance.
Context of Failed Adult-Use Legalization Efforts
The current political climate around adult-use cannabis in Florida is shaped by recent legislative and judicial decisions. The 2024 ballot question, despite garnering majority support, did not achieve the supermajority required for constitutional amendments.
Furthermore, the campaign to place an adult-use cannabis legalization question on the 2026 ballot encountered significant hurdles. Florida officials ruled in February that the campaign had not gathered a sufficient number of valid signatures. This decision was appealed to the state Supreme Court, which ultimately sided with state officials regarding the invalidation of thousands of signatures, many of which were rejected under new policies implemented by Governor Ron DeSantis.
Implications for Florida’s Medical Cannabis Market
The consistent opposition to adult-use reforms among most gubernatorial candidates suggests that the focus for cannabis regulation in Florida will likely remain on the established medical cannabis program. For operators and investors in the state’s medical cannabis sector, this indicates a period of continued stability under the existing regulatory framework, rather than an immediate expansion into a broader adult-use market. The candidates’ emphasis on medical access, particularly for veterans, signals an ongoing commitment to the therapeutic applications of cannabis within controlled parameters.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
